Federal contract award
75A50123C00034
RESEARCH AND DEVELOPMENT - AOI #19 FOR THE DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 FOR COVID19: EXTEND
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $356.4K |
| Current contract value | $356.4K |
| Potential contract value / ceiling | $356.4K |
| Start date | Jul 28, 2023 |
| Current end date | May 31, 2025 |
| Potential end date | May 31, 2025 |
| Latest award activity | Aug 28, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 28, 2025 | P00004 | $-393.0K | RESEARCH AND DEVELOPMENT SERVICES FOR DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 |
| May 2, 2025 | P00003 | $0 | RESEARCH AND DEVELOPMENT SERVICES FOR DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 |
| Jan 28, 2025 | P00002 | $0 | RESEARCH AND DEVELOPMENT - AOI #19 FOR THE DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 FOR COVID19: EXTEND |
| Nov 1, 2024 | P00001 | $0 | RESEARCH AND DEVELOPMENT - AOI #19 FOR THE DEVELOPMENT OF NOVEL OXYGEN THERAPEUTIC NAN02 FOR COVID19: EXTEND |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.